Global market for antifungal therapeutics to grow to $12.2 billion in 2016

The global market for antifungal therapeutics was valued at $10.7 billion in 2011 and is projected to reach $12.2 billion in 2016, a five-year compound annual growth rate (CAGR) of 2.7%.

Learn about applications, both marketed and in development, for antifungal technologies. In an extensive analysis, BCC examines each market segment, presents its current market status, and presents various forecasts for growth over the next five years. Company profiles and patent analysis are also included in this report...

Use this report to:

• Determine the current status of the global human antifungal market and assess the market’s growth potential over the five-year period from 2011 to 2016
• Identify new antifungal research, development, new drug applications, and novel approaches to the market
• Analyze data regarding the market shift for those products that are now relegated to over-the-counter (OTC) status, products which previously required a prescription
• Receive information on industry structure including market shares and also receive patent analysis of the industry.

To provide further information about this report we offer a Complimentary Introduction, available from our Website. To download, simply click here, go to the Table of Contents tab, add the complimentary introduction to your cart, and confirm your order.

RSS Feeds – Pharmaceuticals

GLOBAL SALES OF HUMAN ANTIFUNGALS, 2011 AND 2016

($ MILLIONS)